Update of a phase III trial of adjuvant vinorelbine plus cisplatin (NP) versus NP plus endostar (NPE) in patients with completely resected stage IB-IIIA non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Jie, He
Han, Baohui
Liu, Yongyu
Wu, Shi Xiu
Kuang, Yukang
Shen, Yi
Chen, Chun
Wang, Qun
Li, Qiang
Ma Haitao
Xu, Shaofa
Xu, Shidong
Wang, Ping
Mao, Weimin
Pang, Zuoliang
Hou, Shengcai
Yang, Yue
机构：
[1] Canc Inst Hosp, Beijing, Peoples R China
[2] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Shanghai 200030, Peoples R China
[3] Liaoning Canc Hosp & Inst, Liaoning, Peoples R China
[4] First Hosp, Wenzhou, Peoples R China
[5] Qingdao Univ, Coll Med, Affiliated Hosp, Qingdao 266071, Peoples R China
[6] Fujian Uion Hosp, Fuzhou, Peoples R China
[7] Fudan Univ, Zhongshan Hosp, Shanghai 200433, Peoples R China
[8] Soochow Univ, Affiliated Hosp 1, Suzhou, Peoples R China
[9] Beijing Chest Hosp, Beijing, Peoples R China
[10] Zhejiang Canc Hosp, Hangzhou, Zhejiang, Peoples R China
[11] Xinjiang Canc Hosp, Xinjiang, Peoples R China
[12] Beijing Chaoyang Hosp, Beijing, Peoples R China
[13] Beijing Canc Hosp, Beijing, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18013
引用
收藏
页数：1
相关论文
共 50 条
  • [1] AN UPDATE OF THE PHASE III STUDY OF ADJUVANT VINORELBINE PLUS CISPLATIN (NP) VERSUS NP PLUS ENDOSTAR (NPE) IN PATIENTS WITH COMPLETELY RESECTED STAGE IB-IIIA NON-SMALL CELL LUNG CANCER (NSCLC)
    He, Jie
    Zhang, Xiangru
    Li, Junling
    Han, Baohui
    Liu, Yongyu
    Wu, Shixiu
    Kuang, Y.
    Shen, Yi
    Chen, Chun
    Wang, Qun
    Li, Qiang
    Ma, Haitao
    Xu, Shidong
    Xu, Shaofa
    Wang, P.
    Mao, Weimin
    Pang, Z.
    Hou, S.
    Yang, Y.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1318 - S1319
  • [2] A phase III adjuvant vinorelbine plus cisplatin (NP) versus NP plus endostar (NPE) in patients (pts) with completely resected stage IB-IIIA non-small cell lung cancer (NSCLC): An interim preliminary result.
    Jie, H.
    Xiangru, Z.
    Han, B.
    Liu, Y.
    Wang, Q.
    Xu, S.
    Sheng, Y.
    Li, Q.
    Wu, S.
    Chen, C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [3] Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]):: a randomised controlled trial
    Douillard, Jean-Yves
    Rosell, Rafael
    De Lena, Mario
    Carpagnano, Francesco
    Ramlau, Rodryg
    Gonzales-Larriba, Jose Luis
    Grodzki, Tornasz
    Pereira, Jose Rodrigues
    Le Groumellec, Alain
    Lorusso, Vito
    Clary, Claude
    Torres, Antonio J.
    Dahabreh, Jabrail
    Souquet, Pierre-Jean
    Astudillo, Julio
    Fournel, Pierre
    Artal-Cortes, Angel
    Jassem, Jacek
    Koubkova, Leona
    His, Patricia
    Riggi, Marcella
    Hurteloup, Patrick
    [J]. LANCET ONCOLOGY, 2006, 7 (09): : 719 - 727
  • [4] Randomized Phase III Study of Pemetrexed Plus Cisplatin Versus Vinorelbine Plus Cisplatin for Completely Resected Stage II to IIIA Nonsquamous Non-Small-Cell Lung Cancer
    Kenmotsu, Hirotsugu
    Yamamoto, Nobuyuki
    Yamanaka, Takeharu
    Yoshiya, Katsuo
    Takahashi, Toshiaki
    Ueno, Tsuyoshi
    Goto, Koichi
    Daga, Haruko
    Ikeda, Norihiko
    Sugio, Kenji
    Seto, Takashi
    Toyooka, Shinichi
    Date, Hiroshi
    Mitsudomi, Tetsuya
    Okamoto, Isamu
    Yokoi, Kohei
    Saka, Hideo
    Okamoto, Hiroaki
    Takiguchi, Yuichi
    Tsuboi, Masahiro
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (19) : 2187 - +
  • [5] A phase III clinical trial of adjuvant chemotherapy versus chemoimmunotherapy for stage IB-IIIA completely resected non-small cell lung cancer (NSCLC) patients nadim-adjuvant: New adjuvant trial of chemotherapy versus chemoimmunotherapy.
    Calvo, Virginia
    Domine, Manuel
    Sullivan, Ivana
    Gonzalez-Larriba, Jose-Luis
    Ortega, Ana Laura
    Bernabe, Reyes
    Sala, Maria Angeles
    Campos, Begona
    De Castro, Javier
    Martin-Martorell, Paloma
    Bosch-Barrera, Joaquim
    Mielgo, Xabier
    Vila, Laia
    Casal, Joaquin
    Ros, Silver
    Aguillo, Maite Martinez
    Padilla, Airam
    Sandiego, Sergio
    Machado, Jonathan Aires
    Provencio-Pulla, Mariano
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [6] Adjuvant treatment of completely resected stage IB-IIIA non-small-cell lung cancer - a retrospective study with cisplatin or carboplatin and oral vinorelbine
    Engel-Riedel, W.
    Alten, N.
    Bachinger, A.
    Magnet, F. S.
    Ludwig, C.
    Stoelben, E.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 : S805 - S805
  • [7] Docetaxel plus cisplatin versus vinorelbine plus cisplatin as adjuvant chemotherapy in stage IB-IIIA non-small cell lung cancer: Preliminary result of phase II pilot trial CHL001/TAX622.
    Chu, D.
    Wu, G.
    Han, B.
    Song, X.
    Chen, G.
    Zhou, C.
    Wang, Q.
    Wu, S.
    Wang, Y.
    Zi-Ping, W.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [8] Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial (vol 7, pg 719, 2006)
    Douillard, J-Y
    Rosell, R.
    De Lena, M.
    [J]. LANCET ONCOLOGY, 2006, 7 (10): : 797 - 797
  • [9] A phase III trial comparing the combination of vinorelbine and cisplatin (NP) versus vinorelbine, ifosfamide and cisplatin (NIP) in metastatic non small cell lung cancer patients (NSCLC)
    Price, A
    Souquet, PJ
    Huat, TE
    Clarke, P
    Harper, P
    Pereira, JR
    Van Klaveren, R
    Gatzemeier, U
    Gasmi, J
    [J]. THORAX, 2000, 55 : A86 - A86
  • [10] Adjuvant treatment of completely resected stage IB-IIIA non-small-cell lung cancer. A retrospective study with cisplatin or carboplatin and oral vinorelbine.
    Magnet, Friederike Sophie
    Alten, Nina
    Bachinger, Andreas
    Engel-Riedel, Walburga
    Ludwig, Corinna
    Stoelben, Erich
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
12345